Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.（CYT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CYT · 截至 2026年6月9日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
17
近12个月
买卖比
0.06
Buy/Sell (by trades)
整体情绪
Cyteir Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CYT 季度内部人买卖趋势
CYT 内幕交易卖出 · CYT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
CYT 高管卖出股份 · CYT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 4, 2024 | Gaiero David G CFO | Option | 2,373 | $4K | Form 4 |
| Feb 29, 2024 | Gaiero David G CFO | Option | 4,746 | $8K | Form 4 |
| Feb 29, 2024 | Gaiero David G CFO | Option | 3,239 | $5K | Form 4 |
| Mar 4, 2024 | RENSCHLER MARKUS MD President and CEO · Director | Option | 6,304 | $11K | Form 4 |
| Feb 29, 2024 | RENSCHLER MARKUS MD President and CEO · Director | Option | 2,537 | $3K | Form 4 |
| Feb 29, 2024 | RENSCHLER MARKUS MD President and CEO · Director | Option | 12,607 | $21K | Form 4 |
| Feb 14, 2024 | George Jean Director | Option | 14,150 | $24K | Form 4 |
| Feb 9, 2024 | Sands Stephen H. Director | Option | 12,129 | $20K | Form 4 |
| Feb 8, 2024 | THERO JOHN F Director | Option | 12,828 | $22K | Form 4 |
| Feb 6, 2024 | Zakrzewski Joseph S Director | Option | 14,150 | $24K | Form 4 |
| Dec 11, 2023 | Gaiero David G CFO | Option | 2,373 | $4K | Form 4 |
| Dec 11, 2023 | Gaiero David G CFO | Option | 1,620 | $3K | Form 4 |
| Nov 20, 2023 | RENSCHLER MARKUS MD President and CEO · Director | Option | 2,536 | $3K | Form 4 |
| Nov 20, 2023 | RENSCHLER MARKUS MD President and CEO · Director | Option | 6,304 | $11K | Form 4 |
| Nov 20, 2023 | RENSCHLER MARKUS MD President and CEO · Director | Option | 27,900 | $33K | Form 4 |
| Nov 20, 2023 | RENSCHLER MARKUS MD President and CEO · Director | Option | 56,737 | $96K | Form 4 |
| Nov 20, 2023 | Gaiero David G CFO | Option | 21,356 | $36K | Form 4 |
| Nov 20, 2023 | Gaiero David G CFO | Option | 52,584 | $88K | Form 4 |
| Jul 19, 2023 | Novo Holdings A/S 10 percent owner | Sale | 1,900 | $5K | Form 4 |
| Jul 20, 2023 | Novo Holdings A/S 10 percent owner | Sale | 100,000 | $275K | Form 4 |
| Jul 14, 2023 | Novo Holdings A/S 10 percent owner | Sale | 11,000 | $30K | Form 4 |
| Jul 17, 2023 | Novo Holdings A/S 10 percent owner | Sale | 21,100 | $58K | Form 4 |
| Jul 18, 2023 | Novo Holdings A/S 10 percent owner | Sale | 6,500 | $18K | Form 4 |
| Jun 30, 2023 | Novo Holdings A/S 10 percent owner | Sale | 200,937 | $529K | Form 4 |
| Jun 26, 2023 | Novo Holdings A/S 10 percent owner | Sale | 8,437 | $15K | Form 4 |
RENSCHLER MARKUS MD
President and CEO · Director
日期
Mar 4
股数
6,304
均价
$1.69
总金额
$11K
RENSCHLER MARKUS MD
President and CEO · Director
日期
Feb 29
股数
2,537
均价
$1.20
总金额
$3K
RENSCHLER MARKUS MD
President and CEO · Director
日期
Feb 29
股数
12,607
均价
$1.69
总金额
$21K
RENSCHLER MARKUS MD
President and CEO · Director
日期
Nov 20
股数
2,536
均价
$1.20
总金额
$3K
RENSCHLER MARKUS MD
President and CEO · Director
日期
Nov 20
股数
6,304
均价
$1.69
总金额
$11K
RENSCHLER MARKUS MD
President and CEO · Director
日期
Nov 20
股数
27,900
均价
$1.20
总金额
$33K
RENSCHLER MARKUS MD
President and CEO · Director
日期
Nov 20
股数
56,737
均价
$1.69
总金额
$96K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CYT 内幕交易
CYT 内幕交易
Cyteir Therapeutics, Inc.（CYT）内幕交易数据来源于公司内部人（包括CYT）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。CYT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cyteir Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CYT 内幕交易 · 5个问题Cyteir Therapeutics, Inc.（CYT）的内部人包括高管和董事，如CYT等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026